X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2796) 2796
Publication (208) 208
Newsletter (121) 121
Book Review (47) 47
Newspaper Article (31) 31
Book Chapter (27) 27
Book / eBook (17) 17
Magazine Article (12) 12
Conference Proceeding (3) 3
Government Document (3) 3
Reference (2) 2
Web Resource (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1930) 1930
animals (1437) 1437
index medicus (1418) 1418
antiparasitic agents - therapeutic use (1381) 1381
antiparasitic agents (1249) 1249
male (1031) 1031
female (940) 940
amphotericin b (638) 638
ivermectin - therapeutic use (622) 622
adult (549) 549
middle aged (485) 485
health aspects (452) 452
parasitology (416) 416
treatment outcome (386) 386
antifungal agents - therapeutic use (367) 367
infectious diseases (352) 352
parasitic diseases (334) 334
ivermectin (333) 333
antiparasitic agents - pharmacology (297) 297
pharmacology & pharmacy (287) 287
child (279) 279
microbiology (277) 277
care and treatment (273) 273
veterinary sciences (273) 273
amphotericin b - therapeutic use (268) 268
aged (267) 267
analysis (264) 264
adolescent (243) 243
infection (234) 234
research (228) 228
tropical medicine (227) 227
mice (213) 213
antiparasitic agents - administration & dosage (205) 205
drug therapy (200) 200
infections (190) 190
efficacy (175) 175
immunology (175) 175
drugs (174) 174
mycoses (174) 174
diagnosis (173) 173
parasites (170) 170
dermatology (163) 163
chemotherapy (161) 161
child, preschool (159) 159
in-vitro (157) 157
drug resistance (152) 152
young adult (143) 143
prevalence (140) 140
research article (139) 139
cancer (136) 136
ivermectin - administration & dosage (136) 136
dogs (135) 135
drug therapy, combination (134) 134
risk factors (129) 129
scabies - drug therapy (129) 129
epidemiology (128) 128
medicine (126) 126
parasitic diseases - drug therapy (119) 119
anthelmintics - therapeutic use (117) 117
resistance (117) 117
therapy (117) 117
onchocerciasis - drug therapy (116) 116
antifungal agents (115) 115
chemistry, medicinal (115) 115
tropical diseases (112) 112
medical research (110) 110
medicine, general & internal (110) 110
public, environmental & occupational health (110) 110
transplantation (108) 108
antiparasitic agents - adverse effects (106) 106
antiparasitic agents - chemistry (106) 106
mycology (105) 105
mortality (104) 104
administration, oral (103) 103
anti-bacterial agents - therapeutic use (103) 103
surgery (103) 103
time factors (102) 102
amphotericin b - administration & dosage (100) 100
amphotericin-b (100) 100
fluconazole (100) 100
voriconazole (100) 100
antiprotozoal agents - therapeutic use (99) 99
albendazole - therapeutic use (96) 96
ivermectin - analogs & derivatives (95) 95
usage (95) 95
disease (94) 94
leishmaniasis (94) 94
onchocerciasis (94) 94
feces - parasitology (93) 93
infant (93) 93
antifungal agents - pharmacology (90) 90
albendazole (89) 89
children (88) 88
medical microbiology (87) 87
pediatrics (87) 87
biochemistry & molecular biology (86) 86
internal medicine (86) 86
antifungal agents - administration & dosage (85) 85
retrospective studies (85) 85
dog diseases - drug therapy (84) 84
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2783) 2783
French (62) 62
Spanish (54) 54
German (27) 27
Russian (16) 16
Dutch (14) 14
Polish (10) 10
Chinese (9) 9
Portuguese (7) 7
Japanese (6) 6
Italian (5) 5
Turkish (4) 4
Arabic (3) 3
Danish (3) 3
Swedish (3) 3
Czech (2) 2
Hungarian (2) 2
Finnish (1) 1
Korean (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 11/2012, Volume 67, Issue 11, pp. 2576 - 2597
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 07/2009, Volume 15, Issue 7, pp. 1068 - 1076
Azoles are the mainstay of oral therapy for aspergillosis. Azole resistance in Aspergillus has been reported infrequently. The first resistant isolate in... 
SYSTEM | INFECTIOUS DISEASES | INVASIVE ASPERGILLOSIS | ITRACONAZOLE RESISTANCE | HIGH-RESOLUTION | CROSS-RESISTANCE | ANTIFUNGAL AGENTS | IN-VITRO SUSCEPTIBILITY | MECHANISMS | MUTATIONS | IMMUNOLOGY | CYP51A GENE | Aspergillus fumigatus - drug effects | Humans | Fungal Proteins - drug effects | Azoles - therapeutic use | Fungal Proteins - genetics | Pyrimidines - pharmacology | Aspergillus fumigatus - genetics | Disease Progression | Itraconazole - pharmacology | Antifungal Agents - therapeutic use | Itraconazole - therapeutic use | Triazoles - pharmacology | Cytochrome P-450 Enzyme System - drug effects | Pyrimidines - therapeutic use | Treatment Failure | Voriconazole | Cytochrome P-450 Enzyme System - genetics | Drug Resistance, Fungal | Amino Acid Substitution | Aspergillosis - drug therapy | Evolution, Molecular | Triazoles - therapeutic use | Lung diseases, Obstructive | Care and treatment | Methionine | Mycoses | Transplantation | Drug resistance | Hematopoietic stem cells | Endowments | Algorithms | Codon | Evolutionary biology | Amphotericin B | Gene mutations | Triazoles | Analysis | Antiparasitic agents | Cross infection | Nosocomial infections | Health aspects | Itraconazole | Aspergillus | population genetics | antifungal drug resistance | sterol 14-alpha demethylase CYP51A | Aspergillus fumigatus | azoles
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 10/2010, Volume 16, Issue 10, pp. 1546 - 1553
Journal Article
Psychopharmacology, ISSN 0033-3158, 6/2018, Volume 235, Issue 6, pp. 1697 - 1709
Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 2012, Volume 18, Issue 7, pp. 19 - 37
Journal Article
Nature, ISSN 0028-0836, 04/2010, Volume 464, Issue 7289, pp. 728 - 732
African sleeping sickness or human African trypanosomiasis, caused by Trypanosoma brucei spp., is responsible for similar to 30,000 deaths each year. Available... 
VARIANT SURFACE GLYCOPROTEIN | AFRICAN TRYPANOSOMES | TRYPANOSOMA-BRUCEI | SUBSTRATE PROTEINS | MYRISTOYL-COA | MULTIDISCIPLINARY SCIENCES | COMPLEXES | TRAFFICKING | DRUG TARGET | ENDOCYTOSIS | LEISHMANIA | Acyltransferases - antagonists & inhibitors | Trypanosomiasis, African - drug therapy | Pyrazoles - therapeutic use | Humans | Antiparasitic Agents - metabolism | Aminopyridines - metabolism | Acyltransferases - metabolism | Trypanosoma brucei brucei - enzymology | Aminopyridines - chemistry | Pyrazoles - chemistry | Aminopyridines - therapeutic use | Time Factors | Enzyme Inhibitors - chemistry | Female | Molecular Structure | Trypanosoma brucei brucei - growth & development | Pyrazoles - pharmacology | Enzyme Inhibitors - metabolism | Sulfonamides - chemistry | Enzyme Inhibitors - pharmacology | Rats | Enzyme Assays | Pyrazoles - metabolism | Sulfonamides - pharmacology | Enzyme Inhibitors - therapeutic use | Trypanosoma brucei brucei - drug effects | Antiparasitic Agents - therapeutic use | Trypanosomiasis, African - parasitology | Animals | Sulfonamides - therapeutic use | Aminopyridines - pharmacology | Antiparasitic Agents - pharmacology | Sulfonamides - metabolism | Mice | Antiparasitic Agents - chemistry | Post-translational modification | Usage | Control | Care and treatment | Enzyme inhibitors | Transferases | Physiological aspects | Genetic aspects | Research | Health aspects | Trypanosomiasis | Proteins | Data collection | Enzymes | Human | Inhibitors | Peptides | Central nervous system | Sicknesses | Trypanosome | PARASITES | TRYPANOSOMIASIS | BASIC BIOLOGICAL SCIENCES | SAFETY | SUBSTRATES | VALIDATION | CENTRAL NERVOUS SYSTEM | IN VIVO | 60 APPLIED LIFE SCIENCES | DISEASES | PEPTIDES | TRYPANOSOMA | ENZYMES | IN VITRO | DRUGS | TARGETS | MICE | PROTEINS | TRYPANOSOMES | LEAD COMPOUNDS
Journal Article
Journal Article
Journal Article